Search

Your search keyword '"Doumas, Michalis"' showing total 143 results

Search Constraints

Start Over You searched for: Author "Doumas, Michalis" Remove constraint Author: "Doumas, Michalis"
143 results on '"Doumas, Michalis"'

Search Results

2. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

3. The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients

4. Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry

5. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension

6. SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial

7. Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry

8. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

10. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH

12. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

13. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension

14. Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry

15. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

16. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension

17. Cardiometabolic profile of children with heterozygous familial hypercholesterolemia: Updated data from the HELLAS-FH registry

18. Association of hypertension with cardiovascular profile of adult patients with familial hypercholesterolemia: An analysis from the HELLAS-FH registry

19. Exploring baseline characteristics and achievement of low-density lipoprotein cholesterol targets in Greek children and adults with homozygous familial hypercholesterolemia: Key findings from the HELLAS-FH registry

20. THE IMPACT OF COVID-19 PANDEMIC ON BLOOD PRESSURE CONTROL IN PATIENTS WITH TREATED HYPERTENSION. RESULTS OF EUROPEAN SOCIETY OF HYPERTENSION STUDY (ESH ABPM COVID-19 STUDY)

21. ENDOTHELIAL FUNCTION, AS ASSESSED BY FLOW MEDIATED DILATION AND ASYMMETRIC DIMETHYLARGININE IS IMPAIRED IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS

23. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)

24. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)

25. Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism

26. Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)

27. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH

28. LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

29. Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).

30. Assessment of skin microcirculation in primary aldosteronism: impaired microvascular responses compared to essential hypertensives and normotensives

31. Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH

32. LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

38. Clinical Value of Measuring the Renin/Aldosterone Levels: Optimising the Management of Uncontrolled/Resistant Hypertension

44. A Headache for the Doctor but not for the Patient. Monocytosis, an Exceptional Finding in Giant Cell Arteritis

45. Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study

49. Clinical studies of renal nerve ablation. Unanswered questions for its efficacy and safety

50. Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension

Catalog

Books, media, physical & digital resources